Platelet-Endothelial Interactions in Renal Injury

  • Guy H. Neild
  • Michael P. Gordge
Part of the The Bloomsbury Series in Clinical Science book series (BLOOMSBURY)


The platelet is not only concerned with haemostasis and thrombosis; it is an inflammatory cell with a diversity of actions similar to the monocyte (Nachman and Weksler 1980).


Platelet Aggregation Nephrotic Syndrome Renal Injury Glomerular Injury Focal Segmental Glomerular Sclerosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aarts PAMM, Heethaar RM, Sixma JJ (1984). Red blood cell deformability influences platelets-vessel wall interactions in flowing blood. Blood 64:1228–1233.PubMedGoogle Scholar
  2. Anderson M, Dewar P, Fleming LB, Hacking PM, Morley AR, Murray S et al. (1974) A controlled trial of dipyridamole in human renal transplantation and an assessment of platelet function studies in rejection. Clin Nephrol 2:93–99.PubMedGoogle Scholar
  3. Andrassy K, Ritz E (1985) Uraemia as a cause of bleeding. Am J Nephrol 5:313–319.PubMedGoogle Scholar
  4. Andrassy K, Ritz E, Bommer J (1980) Hypercoagulability in the nephrotic syndrome. Klin Wochenschr 58:1029–1036.PubMedGoogle Scholar
  5. Andrassy K, Ritz E, Mauerhoff T, Bommer J (1982) What is the evidence for activated coagulation in glomerulonephritis? Am J Nephrol 2:293–300.PubMedGoogle Scholar
  6. Appel GB, Blum CB, Chien S, Khin CL, Appel AS (1985) The hyperlipidaemia of the nephrotic syndrome. N Engl J Med 312:1544–1548.PubMedGoogle Scholar
  7. Aviram M, Brook JG (1983) Platelet interaction with high and low density lipoproteins. Atherosclerosis 46:259–268.PubMedGoogle Scholar
  8. Baldwin DS (1982) Chronic glomerulonephritis: non-immunological mechanisms of progressive glomerular damage (Nephrology Forum). Kidney Int 21:109–120.PubMedGoogle Scholar
  9. Ballard HS, Marcus AJ (1972) Primary and secondary platelet aggregation in uraemia. Scand J Haematol 9:198–203.PubMedGoogle Scholar
  10. Bang NU, Trygstad CW, Schroeder JE, Heidenreich RO, Csiscko BM (1973) Enhanced platelet function in glomerular renal disease. J Lab Clin Med 81:651–660.PubMedGoogle Scholar
  11. Barnes JL, Venkatachalam MA (1985) Role of platelets and polycationic mediators in glomerular vascular injury. Semin Nephrol 5:57–68.PubMedGoogle Scholar
  12. Bazilinski N, Shaykh M, Dunea G, Mamdani B, Patel A, Czapek E, Ahmed S (1985) Inhibition of platelet function by uraemic middle molecules. Nephron 40:423–428.PubMedGoogle Scholar
  13. Beaufils M, Uzan S, Donsmoni R, Colan JC (1985) Prevention of pre-eclampsia by early anti-platelet therapy. Lancet I:840–842.Google Scholar
  14. Belch J, Greer I, Prentice CRM (1985) Prostacyclin in the treatment of severe pregnancy-induced hypertension J Clin Exp Hypertension (B) 4:75–86.Google Scholar
  15. Benigni A, Livio M, Dodesini P, Schieppati A, Panigada M, Mecca G, De Gaetano G, Remuzzi G (1985) Inhibition of human platelet aggregation by parathyroid hormone. Am J Nephrol 5:243–247.PubMedGoogle Scholar
  16. Benis J, Rigney J, Sosin A, Deane N (1977) Enhanced platelet aggregation in chronic renal failure patients receiving haemodialysis treatment. Trans Am Soc Artif Organs 23:48–52.Google Scholar
  17. Berretini M, Buoncristiani U, Parise P, Ballatori E, Nenci GG (1981) Polyacrylonitrile versus cuprophane membranes for haemodialysis: evaluation of efficacy and biocompatibility by platelet aggregation studies. Int J Artif Organs 4:218–222.Google Scholar
  18. Bloom A, Greaves M, Preston FE, Brown CB (1986) Evidence against a platelet cyclo-oxygenase defect in uraemic subjects on chronic haemodialysis. Br J Haematol 62:143–149.PubMedGoogle Scholar
  19. Bodzenta A, Thompson JM, Poller L (1980) Prostacyclin activity in amniotic fluid in pre-eclampsia. Lancet 11:650.Google Scholar
  20. Brenner BM, Meyer TW, Hostetter TH (1982) Dietary protein intake and the progressive nature of kidney disease. N Engl J Med 307:652–659.PubMedGoogle Scholar
  21. Brunner FP, Brynger H, Chantier C et al. (1978) Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc 16:28–29.Google Scholar
  22. Bussolino R, Benedetto C, Massorbrio M, Camussi G (1980) Maternal vascular prostacyclin activity in pre-eclampsia. Lancet 11:702.Google Scholar
  23. Cameron JS (1982) Glomerulonephritis: current problems and understanding. J Lab Clin Med 99:755–787.PubMedGoogle Scholar
  24. Cameron JS, Ogg C, Ellis FG, Salmon MA (1971) Femoral arterial thrombosis in nephrotic syndrome. Arch Dis Child 46:215–216.PubMedGoogle Scholar
  25. Camussi G, Arese P, Tetta C, Bussolino F, Coda R, Vercellone A (1983) Platelet activating factor. In: Bertani T, Remuzzi G (eds) Glomerular injury: 300 years after Morgagni. Wichtig Editore, Milan, pp 89–118.Google Scholar
  26. Carreras LO, Machin SJ, Deman R, Defreyn G, Vermylen J, Spitz B, Van Assche A (1981) Arterial thrombosis, intrauterine death and “Lupus” anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet I: 244–246.Google Scholar
  27. Carter AJ, Hanley SP (1985) The effect of platelet number and haematocrit on whole blood thromboxane synthesis. Thromb Haemostas 53:225–227.Google Scholar
  28. Castaldi PA, Rozenberg MC, Stewart JH (1966) Bleeding disorder of uraemia: a qualitative platelet defect. Lancet II:66–69.Google Scholar
  29. Castillo R, Lozano T, Escolar G, Revert L, Lopez J, Ordinas A (1986) Defective platelet adhesion on vessel subendothelium in uraemic patients. Blood 68:337–342.PubMedGoogle Scholar
  30. Cattell V, Mehotra A (1980) Focal mesangial proliferative glomerulonephritis in the rat caused by Habu venom: the effect of anti-platelet agents. Br J Exp Pathol 61:310–314.PubMedGoogle Scholar
  31. Chan MK, Persand JW, Ramdial L, Vargliese Z, Sweny P, Moorhead JF (1981) Hyperlipidaemia in untreated nephrotic syndrome: increased production or decreased removal? Clin Chim Acta 117:317–323.PubMedGoogle Scholar
  32. Chenoweth DE, Cheung AK, Henderson LW (1983) Anaphylotoxin formation during haemodialysis: effects of different dialyser membranes. Kidney Int 24:764–769.PubMedGoogle Scholar
  33. Ciabattoni G, Cinotti GA, Pierucci A, Simonetti BM, Manzi M, Pugliese F et al. (1984) Effects of sulindac and ibuprofen in patients with chronic glomerular disease. N Engl J Med 310:279–283.PubMedGoogle Scholar
  34. Clark WF, Lewis ML, Cameron JS, Parsons V (1975) Intrarenal platelet consumption in the diffuse proliferative nephritis of systemic lupus erythematosus. Clin Sci Mol Med 49:247–252.PubMedGoogle Scholar
  35. Clarkson AR, MacDonald MK, Fuster V, Cash JD, Robson JS (1970) Glomerular coagulation in acute ischaemic renal failure. Q J Med 39:585–598.PubMedGoogle Scholar
  36. Colli S, Maderna P, Tremoli E, Baraldi A, Rovati GE, Gianfranceschi G, Nicosia S (1985) Prostacyclin-lipoprotein interactions. Studies on human platelet aggregation and adenylate cyclase. Biochem Pharmacol 34:2451–2457.PubMedGoogle Scholar
  37. Cotran RS (1982) Glomerulosclerosis in reflux nephropathy. Kidney Int 21:528–534.PubMedGoogle Scholar
  38. Curry RC, Roberts WC (1977) Status of the coronary arteries in the nephrotic syndrome. Am J Med 63:183–192.PubMedGoogle Scholar
  39. Dadak C, Kefalides A, Sinzinger H (1985) Prostacyclin synthesis stimulating plasma factor and platelet sensitivity in pre-eclampsia. Biol Res Pregnancy Perinatol 6:65–69.PubMedGoogle Scholar
  40. Defreyn G, Vergara-Danden M, Machin SJ, Vermylen J (1980) A plasma factor in uraemia which stimulates prostacyclin release from cultured endothelial cells. Thromb Res 19:695–699.PubMedGoogle Scholar
  41. Deuel TF, Senior RM, Chang D, Griffin GL, Henrikson RL, Kaiser ET (1981) Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci USA 78:4584–4587.PubMedGoogle Scholar
  42. Deuel TF, Senior RM, Huang JS, Griffin GL (1982) Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest 69:1046–1049.PubMedGoogle Scholar
  43. Di Minno G, Martinez J, McKean M, De La Rosa J, Burke JFF, Murphy S (1985) Platelet dysfunction in uraemia. Multifactorial defect partially corrected by dialysis. Am J Med 79:552–559.Google Scholar
  44. Dodd NJ, Gordge MP, Weston MJ (1983) Use of a thromboxane synthetase inhibitor, Dazoxiben, during haemodialysis. Br J Clin Pharmacol 15:67S–70S.PubMedGoogle Scholar
  45. Donadio JV, Anderson CF, Mitchell JL, Holley KE, Ilstrup DM, Fuster V, Chesebro JH (1984) Mem-brano-proliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. N Engl J Med 310:1421–1426.PubMedGoogle Scholar
  46. Du XH, Glas-Greenwatt P, Kauts KS, Allen CM, Hayes S, Pollak VE (1985) Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (α-2 antiplasmin). Clin Nephrol 24:186–191.PubMedGoogle Scholar
  47. Duffus P, Parbtani A, Frampton G, Cameron JS (1982) Intraglomerular localisation of platelet-related antigens, platelet factor 4 and ?-thromboglobulin in glomerulonephritis. Clin Nephrol 18:298–302.Google Scholar
  48. Duffy JL, Cinque T, Grishman E, Churg J (1970) Intraglomerular fibrin, platelet aggregation and subendothelial deposits in lipoid nephrosis. J Clin Invest 49:251–258.PubMedGoogle Scholar
  49. Editorial (1982) Pregnancy and the arachidonic acid cascade. Lancet I:997–998.Google Scholar
  50. Eknoyan G, Brown CH (1981) Biochemical abnormalities of platelets in renal failure. Am J Nephrol 1:17–23.PubMedGoogle Scholar
  51. Evans EP, Branch RA, Bloom AL (1972) A clinical and experimental study of platelet function in chronic renal failure. J Clin Pathol 25:745–753.PubMedGoogle Scholar
  52. Fernandez F, Gondable C, Sie P, Ton-That H, Durand D, Suc JM, Bonen B (1985) Low haematocrit and prolonged bleeding time in uraemic patients; effect of red cell transfusions. Br J Haematol 59:139–148.PubMedGoogle Scholar
  53. Fidler J, Ellis C, Bennett MJ, de Swiet M, Lewis PJ (1981) Prostacyclin and pre-eclamptic toxaemia. In: Lewis PJ, O’Grady J (eds) Clinical pharmacology of prostacyclin. Raven Press, New York.Google Scholar
  54. Firkin BG, Howard MA, Radford N (1980) Possible relationship between Lupus inhibitor and recurrent abortion in young women. Lancet II:366.Google Scholar
  55. Fisher-Hoch SP, Platt GS, Lloyd G, Simpson DIH, Neild GH, Barrett AJ (1983) Haematological and biochemical monitoring of Ebola infection in Rhesus monkeys. Lancet II:1055–1058.Google Scholar
  56. Fisher-Hoch SP, Platt GS, Neild GH, Southee T, et al. (1985) Pathophysiology of shock and haemorrhage in a fulminating viral infection (Ebola). J Inf Dis 152:887–894.Google Scholar
  57. Fong JSC, Kaplan BS (1982) Impairment of platelet aggregation in haemolytic uraemic syndrome: evidence for platelet “exhaustion”. Blood 60:564–570.PubMedGoogle Scholar
  58. Forbes RDC, Guttman RD (1982) Evidence for complement-induced endothelial injury, in vivo. Am J Pathol 106:378–387.PubMedGoogle Scholar
  59. Forbes RDC, Kuramochi T, Guttman RD, Klassen J, Knaack J (1975) A controlled sequential morphological study of hyperacute cardiac allograft rejection in the rat. Lab Invest 33:280–288.PubMedGoogle Scholar
  60. Futrakul P (1980) A new therapeutic approach of nephrotic syndrome associated with focal segmental glomerulosclerosis. Int J Paediatr Nephrol 1:18–21.Google Scholar
  61. Futrakul P, Poshyachinda M (1977) Kinetic evaluation of haemostasis in the steroid-sensitive nephrotic syndrome. J Singapore Paediatr Soc 19:273–276.PubMedGoogle Scholar
  62. Futrakul P, Poshyachinda M, Mitrakul C (1978) Focal sclerosing glomerulonephritis: a kinetic evaluation of haemostasis and the effect of anticoagulant therapy: a controlled study. Clin Nephrol 10:180–186.PubMedGoogle Scholar
  63. Gabbiani G, Badonnel MC, Vassalli P (1975) Experimental focal glomerular lesions elicited by insoluble immune complexes. Lab Invest 32:33–45.PubMedGoogle Scholar
  64. George CRP, Slichter SJ, Quadracci LJ, Striker GE, Harker LA (1974) A kinetic evaluation of haemostasis in renal disease. N Engl J Med 293:1111–1115.Google Scholar
  65. George JN, Nurden AT, Phillips DR (1984) Molecular defects in interactions of platelets with the vessel wall. N Engl J Med 311:1084–1098.PubMedGoogle Scholar
  66. Goodman RP, Killam AP, Brash AR, Branch RA (1982) Prostacyclin production during pregnancy: comparison of production during normal pregnancy and pregnancy complicated by hypertension. Am J Obstet Gynecol 142:817–822.PubMedGoogle Scholar
  67. Gordge MP, Dodd NJ, Rylance PB, Weston MJ (1984) An assessment of whole blood impedance aggregometry using blood from normal subjects and haemodialysis patients. Thromb Res 36:17–27.PubMedGoogle Scholar
  68. Gorog P, Shraufistatter I, Born GVE (1982) Effect of removing sialic acid from endothelium on the adherence of circulating platelets in arteries in vivo. Proc R Soc Lond 214:471–480.PubMedGoogle Scholar
  69. Grandel KE, Farr RS, Wanderer AA, Eisenstadt TC, Wasserman SI (1985) Association of platelet-activating factor with primary acquired cold urticaria. N Engl J Med 313:405–409.PubMedGoogle Scholar
  70. Gura V, Creter D, Levi J (1982) Elevated thrombocyte calcium content in uraemia and its correction by l-a-(OH)-Vitamin D treatment. Nephron 30:237–239.PubMedGoogle Scholar
  71. Harker LA, Slichter SJ (1972) Platelet and fibrinogen consumption in man. N Engl J Med 287:999–1005.PubMedGoogle Scholar
  72. Harlan JM, Harker LA (1981) Hemostasis, thrombosis and thromboembolic disorders: the role of arachidonic acid metabolites in platelet-vessel wall interactions. Med Clin N Am 65:855–880.PubMedGoogle Scholar
  73. Heptinstall RH (1983) Renal disease in pregnancy. In: Heptinstall RH (ed) Pathology of the kidney vol 2. Little, Brown and Co., Boston Toronto, pp 963–991.Google Scholar
  74. Horowitz HI, Stein IM, Cohen BD, White JG (1970) Further studies on the platelet-inhibitory effect of guanidosuccinic acid and its role in uraemic bleeding. Am J Med 49:336–345.PubMedGoogle Scholar
  75. Howard MA, Whitworth JA, Hendrix LE, Thomas KB, Furkin BG (1979) Abnormal FVIII in chronic renal failure. Med J Aust 1:148–151.PubMedGoogle Scholar
  76. Howie PW, Prentice CRM, Forbes CD (1979) Failure of heparin therapy to affect the clinical course of severe pre-eclampsia. Br J Obstet Gynaecol 82:711–717.Google Scholar
  77. Hughes A, Tonks RS (1962) Intravascular platelet clumping in rabbits. J Pathol Bacteriol 84:379–390.PubMedGoogle Scholar
  78. Hunsicker LG, Shearer TP, Shaffer SJ (1981) Acute reversible proteinuria induced by infusion of the poly-cation hexadimethrine. Kidney Int 20:7–17.PubMedGoogle Scholar
  79. Ichikawa I, Brenner BM (1979) Mechanism of action of histamine and histamine antagonists on the glomerular microcirculation in the rat. Circ Res 45:737–745.PubMedGoogle Scholar
  80. Inamo Y, Shimeda M, Okumi M (1984) Nephrotic syndrome in children. Relationship among hypo-albuminaemia, serum lipid abnormalities and elevation of thromboxane B2. Nikon Univ J Med 26:291–298.Google Scholar
  81. Inauen W, Staubli M, Descoeudres C, Galeazzi RL, Straub PW (1982) Erythrocyte deformability in dialysed and non-dialysed uraemic patients. Eur J Clin Invest 12:173–176.PubMedGoogle Scholar
  82. Jackson CA, Greaves M, Patterson AD, Brown CB, Preston FE (1982) Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome. Br J Haematol 52:69–77.PubMedGoogle Scholar
  83. Jacob A, Gavellas G, Zarco R, Perez G, Bourgoignie JJ (1980) Leucopenia, hypoxia and complement function with different haemodialysis membranes. Kidney Int 18:505–509.PubMedGoogle Scholar
  84. Janson PA, Jubelirer SJ, Weinstein MJ, Deykin D (1980) Treatment of the bleeding tendency of uraemia with cryoprecipitate. N Engl J Med 303:1318–1322.PubMedGoogle Scholar
  85. Jorgensen L, Rowsell HC, Hovig T, Glynn MF, Mustard JF (1967) Adenosine diphosphate induced platelet aggregation and myocardial infarction in swine. Lab Invest 17:616.PubMedGoogle Scholar
  86. Jorgensen L, Glynn MF, Hovig T, Murphy EA, Buchanan MR, Mustard JF (1970a) Renal lesion and rise in blood pressure caused by adenosine diphosphate-induced platelet aggregation in rabbits. Lab Invest 23:347–357.PubMedGoogle Scholar
  87. Jorgensen L, Hovig T, Rowsell HC, Mustard JF (1970b) Adenosine diphosphate-induced platelet aggregation and vascular injury in swine and rabbits. Am J Pathol 61:161–170.PubMedGoogle Scholar
  88. Jubelirer SJ (1985) Hemostatic abnormalities in renal disease. Am J Kidney Dis 5:219–225.PubMedGoogle Scholar
  89. Kanfer A (1984) Coagulation system in acute renal failure. In: Andreucci VE (ed) Acute renal failure. Martinus Nijhoff, The Hague, pp 177–185.Google Scholar
  90. Kanfer A, Kleinkrecht D, Broyer M, Josso F (1970) Coagulation studies in 45 cases of nephrotic syndrome without uraemia. Thromb Diathes Haemorrh 24:562–571.Google Scholar
  91. Kasai N, Parbtani A, Cameron JS, Yewdall V, Shepherd P, Verroust P (1981) Platelet-aggregating immune complexes and intra-platelet serotonin in idiopathic glomerulonephritis and systemic lupus. Clin Exp Immunol 43:64–72.PubMedGoogle Scholar
  92. Kazatchkine M, Sutton Y, Caen JP, Bariety J (1976) Bleeding in renal failure: a possible cause. Br Med J ii:612–615.Google Scholar
  93. Kincaid-Smith P (1972) The treatment of chronic mesangiocapillary (membrano-proliferative) glomerulonephritis with impaired renal function. Med J Aust 2:587–592.PubMedGoogle Scholar
  94. Kincaid-Smith P (1984) Anti-coagulants are of value in the treatment of renal disease. Am J Kidney Dis 3:299–307.PubMedGoogle Scholar
  95. Kincaid-Smith P, Laver MC, Fairley KF (1970) Dipyridamole and anticoagulants in renal disease due to glomerular and vascular lesions. Med J Aust 1:145–151.PubMedGoogle Scholar
  96. King GL, Buchwald S (1984) Characterisation and partial purification of an endothelial cell growth factor from human platelets. J Clin Invest 73:392–396.PubMedGoogle Scholar
  97. Klahr S, Buerkert J, Purkerson ML (1983) Role of dietary factors in the progression of chronic renal disease. Kidney Int 24:579–587.PubMedGoogle Scholar
  98. Kniker WT, Cochrane CG (1968) The localisation of circulating immune complexes in experimental serum sickness. J Exp Med 127:119–135.PubMedGoogle Scholar
  99. Knudsen F, Nielsen AH, Kornerup HJ, Pedersen JC, Dyerberg J (1984) Epoprostenol as sole antithrombotic treatment during haemodialysis. Lancet II:235–236.Google Scholar
  100. Koyama A, Inage H, Sano M, Narita M, Jojo S, Neild GH, Cameron JS (1985) Platelet involvement in the nephritis of acute serum sickness in rabbits: protection by dipyridamole and FUT-175. Clin Exp Immunol 61:388–396.PubMedGoogle Scholar
  101. Kristensen SD, Knudsen F, Nielsen AH, Ring T (1984) Decreased platelet sensitivity to prostacyclin (epoprostenol) during haemodialysis. Clin Nephrol 21:230–234.PubMedGoogle Scholar
  102. Kuhlback B (1957) Bleeding tendency in chronic renal failure. Acta Med Scand 157:173–177.PubMedGoogle Scholar
  103. Kurtz TW, Slavicek JM, Hsu CH (1982) Blood viscosity in experimental acute renal failure. Nephron 30:348–351.PubMedGoogle Scholar
  104. Larsson SO, Hedner V, Nilsson IM (1971) On coagulation and fibrinolysis in acute renal insufficiency. Acta Med Scand 189:443–451.PubMedGoogle Scholar
  105. Lau SO, Tkachuk JY, Haseguara DK, Edson JR (1980) Plasminogen and antithrombin III deficiencies in the childhood nephrotic syndrome associated with plasminoglysuria and antithrombinuria. J Paediatr 96:390–392.Google Scholar
  106. Lavelle KJ, Noseman AM (1978) The influence of selective thrombocytopenia on immune complex glomerulonephritis. J Lab Clin Med 192:737–749.Google Scholar
  107. Lavelle KJ, Ransdell BA, Kleit SA (1976) The influence of selective thrombocytopenia on nephrotoxic nephritis. J Lab Clin Med 87:967–975.PubMedGoogle Scholar
  108. Leithner C, Kovarik J, Sinzinger H, Woloszcuk W (1984) Parathyroid hormone does not inhibit platelet aggregation. Lancet I:367–368.Google Scholar
  109. Levin M, Nokes TJC, Hardisty RM, Barratt TM (1981) Spontaneous platelet aggregation in renal disease. Int J Paediatr Nephrol 2:147.Google Scholar
  110. Levin M, Smith C, Walters MDS, Gascoine P, Barratt TM (1985) Steroid-responsive nephrotic syndrome: a generalised disorder of membrane negative charge. Lancet II:239–242.Google Scholar
  111. Lewis JH, Zucker MB, Ferguson JH (1956) Bleeding tendency in uraemia. Blood 11:1073–1076.PubMedGoogle Scholar
  112. Lindner A, Charra B, Sherrard DJ, Scribner BH (1974) Accelerated atherosclerosis in prolonged maintenance haemodialysis. N Engl J Med 290:697–701.PubMedGoogle Scholar
  113. Lindsay RM, Prentice CRM, Davidson JF, Burton JA, McNichol GP (1972a) Haemostatic changes dur-ing dialysis associated with thrombus formation on dialysis membrane. Br Med J iv:454–458.Google Scholar
  114. Lindsay RM, Ferguson D, Prentice CRM, Burton JA, McNichol GP (1972b) Reduction of thrombus formation on dialyser membranes by aspirin and RA233. Lancet II:1287.Google Scholar
  115. Lindsay RM, Moorthy AV, Koens F, Linton AL (1975) Platelet function in dialysed and non-dialysed patients with chronic renal failure. Clin Nephrol 4:52–57.PubMedGoogle Scholar
  116. Lindsay RM, Friesen M, Koens F, Linton AL, Oreopoulos D, DeVeber G (1976) Platelet function in patients on long-term peritoneal dialysis. Clin Nephrol 6:335–339.PubMedGoogle Scholar
  117. Livio M, Gotti E, Marchesi D, Mecca G, Remuzzi G, De Gaetano G (1982) Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet II: 1013–1015.Google Scholar
  118. Llach F (1985) Hypercoagulability, renal vein thrombosis and other thrombotic complications of nephrotic syndrome. Kidney Int 28:429–439.PubMedGoogle Scholar
  119. Lubbe WF, Butler WS, Palmer SJ, Liggins GC (1983) Fetal survival after prednisone suppression of maternal Lupus anticoagulant. Lancet I:1361–1363.Google Scholar
  120. Mabuchi H, Nakahashi H (1983) Isolation and partial characterisation of platelet aggregation inhibitors in the blood of dialysed patients. Nephron 35:112–115.PubMedGoogle Scholar
  121. Majno G, Shea SM, Leventhal M (1969) Endothelial contraction induced by histamine-type mediators. J Cell Biol 42:647–672.PubMedGoogle Scholar
  122. Mallick NP, Short CD (1981) The nephrotic syndrome and ischaemic heart disease. Nephron 27:54–57.PubMedGoogle Scholar
  123. Mannuchi PM, Remuzzi G, Pusineri F, Lombardi R, Valsechi C, Mecca G, Zimmerman TS (1983) Deamino-8-D-arginine vasopressin shortens the bleeding time in uraemia. N Engl J Med 308:8–12.Google Scholar
  124. McGinley E, Lowe GDO, Boulton Jones M, Forbes CD, Prentice CRM (1983) Blood viscosity and haemostasis in the nephrotic syndrome. Thromb Haemostas 49:155–157.Google Scholar
  125. McKay DG (1973) Blood coagulation and renal disease. In: Kincaid-Smith P, Mathew TH, Becker EL (eds) Glomerulonephritis. Wiley, New York, pp 771–887.Google Scholar
  126. McKay DG, Linder MM, Cruse VK (1971) Mechanisms of thrombosis of the microcirculation. Am J Pathol 63:231–241.PubMedGoogle Scholar
  127. Meade TW, Vickers MV, Thompson SG, Seghatchiean MJ (1985) The effect of physiological levels of fibrinogen on platelet aggregation. Thromb Res 38:527–534.PubMedGoogle Scholar
  128. Miller K, Dresner IG, Michael AF (1980) Localisation of platelet antigens in human kidney disease. Kidney Int 18:472–479.PubMedGoogle Scholar
  129. Moore S, Lough J (1970) Lipid accumulation in renal arterioles due to platelet aggregate embolism. Am J Pathol 58:283.PubMedGoogle Scholar
  130. Myers BD, Moran SM (1986) Hemodynamically mediated acute renal failure. N Engl J Med 314:97–105.PubMedGoogle Scholar
  131. Nachman RL, Weksler BB (1980) The platelet as an inflammatory cell. In: Weissman G (ed) The cell biology of inflammation. Elsevier, Amsterdam, pp 145–162.Google Scholar
  132. Neild GH (1983) Mechanisms and models of endothelial injury. In: Bertani T, Remuzzi G (eds) Glomerular injury: 300 years after Morgagni. Wichtig Editore, Milan, pp 139–162.Google Scholar
  133. Neild GH, Rocchi G, Imberti L, Fumagalli F, Brown Z, Remuzzi G, Williams DG (1983) Effect of cyclosporin A on prostacyclin synthesis by vascular tissue. Thromb Res 32:373–379.PubMedGoogle Scholar
  134. Neild GH, Ivory K, Williams DG (1984a) Glomerular thrombosis and cortical infarction in cyclosporin-treated rabbits with acute serum sickness. Br J Exp Pathol 65:133–144.PubMedGoogle Scholar
  135. Neild GH, Ivory K, Williams DG (1984b) Severe systemic vascular necrosis in cyclosporin-treated rabbits with acute serum sickness. Br J Exp Pathol 65:731–743.PubMedGoogle Scholar
  136. Nenci GG, Berrettini M, Agnelli G, Parise P, Buoncristiani V, Ballarori E (1979) Effect of peritoneal dialysis, haemodialysis and kidney transplantation on blood platelet function. Nephron 23:287–292.PubMedGoogle Scholar
  137. Nordoy A, Svensson V, Wiebe D, Hoak J (1978) Lipoproteins and the inhibitory effect of human endothelial cells on platelet function. Circulation Res 43:527–534.PubMedGoogle Scholar
  138. Ozanne P, Francis RB, Meiselman HJ (1983) Red blood cell aggregation in nephrotic syndrome. Kidney Int 23:519–525.PubMedGoogle Scholar
  139. Panicucci F, Sagripanti A, Vispi M, Pinori E, Lecchini L, Barsotti G, Giovanetti S (1983) Comprehensive study of haemostasis in nephrotic syndrome. Nephron 33:9–13.PubMedGoogle Scholar
  140. Parbtani A, Cameron JS (1980) Platelet involvement in glomerulonephritis. In: Remuzzi G, Mecca G, de Gaetano G (eds) Haemostasis, prostaglandins and renal disease. Raven Press, New York, pp 45–61.Google Scholar
  141. Parbtani A, Frampton G, Cameron JS (1979) Measurements of platelet release substances in glomerulonephritis. A comparison of β-thromboglobulin, platelet factor 4, and serotonin assays. Thromb Res 19:177–189.Google Scholar
  142. Parbtani A, Frampton G, Cameron JS (1980a) Platelet and plasma serotonin concentrations in glomerulonephritis II. Clin Nephrol 14:112–123.PubMedGoogle Scholar
  143. Parbtani A, Frampton G, Kasai N, Yewdall V, Cameron JS (1980b) Platelet and plasma serotonin concentrations in glomerulonephritis. III. The nephritis of systemic lupus erythematosus. Clin Nephrol 14:164–172.PubMedGoogle Scholar
  144. Patrono C, Ciabattoni G, Remuzzi G, Gotti E, Bombardieri S et al. (1985) Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J Clin Invest 76:1011–1018.PubMedGoogle Scholar
  145. Prentice CRM (1980) Intravascular coagulation in pre-eclampsia: cause or consequence? In: Remuzzi G, Mecca G, de Gaetano G (eds) Hemostasis, prostaglandins and renal disease. Raven Press. New York, pp 347–351.Google Scholar
  146. Puenis J, Rigney J, Sosin A, Deane N (1977) Enhanced platelet aggregation in chronic renal failure patients receiving haemodialysis treatment. Trans Am Soc Artif Intern Organs 23:48.Google Scholar
  147. Purkerson ML (1985) Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci USA 82:193–197.PubMedGoogle Scholar
  148. Purkerson ML, Hoffsten PE, Klahr S (1976) Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 9:407–417.PubMedGoogle Scholar
  149. Purkerson ML, Joist JH, Greenberg JM, Kay D, Hoffsten PE, Klahr S (1982) Inhibition by anti-coagulant drugs of the progressive hypertension and uraemia associated with renal infarction in rats. Thromb Res 26:227–240.PubMedGoogle Scholar
  150. Rabiner SF, Hroder O (1968) Platelet factor 3 in normal subjects and patients with renal failure. J Clin Invest 47:346–351.Google Scholar
  151. Rabiner SF, Molinas F (1970) The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation of patients with renal failure. Am J Med 49:346–351.PubMedGoogle Scholar
  152. Remuzzi G, Livio M, Cavenaghi AE, Marchusi D, Mecca D, Donati MB, De Gaetano G (1978a) Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding. A hypothesis. Thromb Res 13:531–536.PubMedGoogle Scholar
  153. Remuzzi G, Livio M, Marchiaro G, Mecca G, De Gaetano G (1978b) Bleeding in renal failure: altered platelet function in chronic uraemia only partially corrected by haemodialysis. Nephron 22:347–353.PubMedGoogle Scholar
  154. Remuzzi G, Marchesi D, Livio M, Cavenaghi AE, Mecca G, Donati MB, De Gaetano G (1978c) Altered platelet and vascular prostaglandin generation in patients with renal failure and prolonged bleeding times. Thromb Res 13:1007–1015.PubMedGoogle Scholar
  155. Remuzzi G, Marchesi D, Cavenaghi AE, Livio M, Donati MB, De Gaetano G, Mecca G (1979a) Bleeding in renal failure: a possible role of vascular prostacyclin (PGI2). Clin Nephrol 12:127–131.PubMedGoogle Scholar
  156. Remuzzi G, Mecca G, Marchesi D, Livio M, De Gaetano G, Donati MB, Silver MJ (1979b) Platelet hyperaggregability in the nephrotic syndrome. Thromb Res 16:345–353.PubMedGoogle Scholar
  157. Remuzzi G, Marchesi D, Zoja C, Muratore D, Mecca G, Misiani R, Rossi E, Barbato M, Capetta P, Donati MB, De Gaetano G (1980) Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins 20:105–110.PubMedGoogle Scholar
  158. Remuzzi G, Zoja C, Marchesi D, Schieppati A, Mecca G, Misiani R, Donati MB, De Gaetano G (1981) Plasmatic regulation of vascular prostacyclin in pregnancy. Br Med J 282:512–514.Google Scholar
  159. Remuzzi G, Benigni A, Dodesini P, Schieppati A, Gotti E, Livio M, Mecca G, Donati MS, De Gaetano G (1982) Platelet function in patients on maintenance haemodialysis: depressed or enhanced? Clin Nephrol 17:60–63.PubMedGoogle Scholar
  160. Remuzzi G, Benigni A, Dodesini P, Shieppati A, Livio M, De Gaetano G, Doy JS, Smith WL, Pinca E, Patrignami P, Patrono C (1983) Reduced platelet thromboxane formation in uraemia. Evidence for a functional cyclo-oxygenase defect. J Clin Invest 71:762–768.PubMedGoogle Scholar
  161. Richman AV, Kasnic G (1982) Endothelial and platelet reactions in the idiopathic nephrotic syndrome: an ultrastructural study. Hum Pathol 13:548–553.PubMedGoogle Scholar
  162. Riesman D (1907) Haemorrhages in the course of Blight’s disease with especial reference to the occurrence of a hemorrhagic diathesis of nephrotic origin. Am J Sci 134:709–716.Google Scholar
  163. Ruggeri ZM, Ponticelli C, Marmucci PM (1977) FVIII and chronic renal failure. Br Med J i:1085.Google Scholar
  164. Rylance PB, Gordge MP, Ireland H, Lane DA, Weston MJ (1984a) Haemodialysis with prostacyclin (epoprostanol) alone. Proc Eur Dial Transplant Assoc 21:281–286.Google Scholar
  165. Rylance PB, Gordge MP, Ireland H, Lane DA, Weston MJ (1984b) Low molecular weight heparin as an alternative to unfractionated heparin during haemodialysis. Proc Eur Dial Transplant Assoc 21:108(abstr).Google Scholar
  166. Rylance PB, Gordge MP, Weston MJ (1985a) Correction of citrate concentration is necessary in platelet aggregatory studies in uraemia. Clin Nephrol 23:155–156.PubMedGoogle Scholar
  167. Rylance PB, Gordge MP, Weston MJ (1985b) Platelet function is enhanced, not depressed in uraemia. Proc Eur Dial Transplant Assoc 22:946–952.Google Scholar
  168. Rylance PB, Dodd NJ, Gordge MP, Neild GH, Weston MJ (1986) The therapeutic use of prostacyclin (epoprostenol) infusion in acute renal failure associated with consumptive coagulopathy. In: Neri Ser-neri GG (ed) Platelets, prostaglandins and the cardiovascular system. Raven Press, New York (in press).Google Scholar
  169. Salzman EW, Neri LL (1966) Adhesiveness of blood platelets in uraemia. Thromb Diathes Haemorrh 15:84–92.Google Scholar
  170. Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L (1980) Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 65:64–73.PubMedGoogle Scholar
  171. Schwartz MM, Cotran RS (1972) Vascular leakage in the kidney and lower urinary tract: effects of histamine, serotonin and bradykinin. Proc Soc Exp Biol Med 140:535–539.PubMedGoogle Scholar
  172. Senior RM, Griffin GL, Huang JS et al. (1983) Chemotactic activity of platelet ?-granule proteins for fibroblasts. J Cell Biol 96:382–385.PubMedGoogle Scholar
  173. Shattil SJ, Bennett JS, Colman RW, Cooper RA (1977) Abnormalities of cholesterol phospholipid composition in platelets and low density lipoproteins of human hyperbetalipoproteinaemia. J Lab Clin Med 89:341–353.PubMedGoogle Scholar
  174. Shigematsu H, Niwa Y, Takizawa J, Akikusa B (1979) Arthus-type nephritis. I. Characterisation of glomerular lesions induced by insoluble and poorly soluble immune complexes. Lab Invest 40:492–502.PubMedGoogle Scholar
  175. Silver MJ, Smith JB, Ingema CM, Kocsis JJ (1973) Arachidonic acid induced human platelet aggregation and prostaglandin formation. Prostaglandins 4:863–875.PubMedGoogle Scholar
  176. Sindrey M, Marshall TL, Naish P (1979) Quantitative assessment of the effects of platelet depletion in the autologous phase of nephrotoxic serum nephritis. Clin Exp Immunol 36:90–96.PubMedGoogle Scholar
  177. Smith MC, Dunn MJ (1981) Impaired platelet thromboxane production in renal failure. Nephron 29:133–137.PubMedGoogle Scholar
  178. Smith MC, Danvinyasup K, Crow JW, Cato AE, Park GD, Hassin A, Dunn MJ (1982) Prostacyclin substitution for heparin in long-term haemodialysis. Am J Med 73:669–678.PubMedGoogle Scholar
  179. Sozska J, Rydzewski A, Mysliwiec M (1983) Normal response of uraemic platelets to thromboxane A2 agonist. Nephron 35:262–268.Google Scholar
  180. Steiner RW, Coggins C, Carvalho CA (1979) Bleeding time in uraemia: a useful test to assess clinical bleeding. Am J Haematol 7:107–117.Google Scholar
  181. Stewart JH, Castaldi PA (1967) Uraemic bleeding: a reversible platelet defect corrected by dialysis. Q J Med 36:408–423.Google Scholar
  182. Strano A, Davi G, Averna M, Rini GB, Novo S, DiFede G, Mattina A, Nortabartano A (1982) Platelet sensitivity to prostacyclin and thromboxane production in hyperlipidaemic patients. Thromb Haemost 48:18–20.PubMedGoogle Scholar
  183. Striker GE, Striker LJ (1985) Biology of disease: glomerular cell culture. Lab Invest 53:122–131.PubMedGoogle Scholar
  184. Stuart MJ, Gerrard JM, White JG (1980) The influence of albumin and calcium on human platelet arachidonic acid metabolism. Blood 55:418–423.PubMedGoogle Scholar
  185. Stuart MJ, Clark DA, Sunderji SG, Allen JB, Yambo T, Elrad H, Slott JH (1981) Decreased prostacyclin production: a characteristic of chronic placental insufficiency syndromes. Lancet I:1126–1128.Google Scholar
  186. Symchych PS, Perrin EU (1965) Thrombosis of the main pulmonary artery in nephrosis. Thromboembolism as a complication of nephrosis. Am J Dis Child 110:636–642.PubMedGoogle Scholar
  187. Thompson C, Forbes CD, Prentice CRM, Kennedy AC (1974) Changes in blood coagulation and fibrinolysis in the nephrotic syndrome. Q J Med 43:399–407.Google Scholar
  188. Tison P, Cernacek P, Silvanova E, Dzurik R (1981) Uraemic toxins and blood platelet carbohydrate metabolism. Nephron 28:192–195.PubMedGoogle Scholar
  189. Tomura S, Ida T, Kuriyama R, Chida Y, Takenchi J, Motomiiya T, Yamazaki H (1982) Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome. Clin Nephrol 17:24–30.PubMedGoogle Scholar
  190. Turitto VT, Weiss HJ (1980) Red blood cells: their dual role in thrombus formation. Science 207:541–543.PubMedGoogle Scholar
  191. Turney JH, Williams LC, Fewell MR, Parsons V, Weston MJ (1980) Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy. Lancet II:219–222.Google Scholar
  192. Turney JH, Woods HF, Fewell MR, Weston MJ (1981) Factor VIII complex in uraemia and effects of haemodialysis. Br Med J 282:1653–1656.Google Scholar
  193. Uttley JMC, Elton RA, Hill CM, MacDonald MK (1985) Incidence of intraglomerular platelets in steroid-sensitive nephrotic syndrome. J Clin Pathol 38:259–264.PubMedGoogle Scholar
  194. Vassalli P, Simon G, Rouiller C (1963) Electron microscopic study of glomerular lesions resulting from intravascular fibrin formation. Am J Pathol 43:579–611.PubMedGoogle Scholar
  195. Vicente V, Alberca I, Macias JF, Lopez Borrasca A (1984) DDAVP in uraemia. Nephron 36:145–146.PubMedGoogle Scholar
  196. Wallenburg ACS, Dekker GA, Makovitz JW, Rotmans P (1986) Low dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin sensitive Primigravidae. Lancet I:1–3.Google Scholar
  197. Walsh SW (1985) Pre-eclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 152:335–340.PubMedGoogle Scholar
  198. Walter E, Deppermann D, Andrassy K, Koderish J (1981) Platelet hyperaggregability as a consequence of the nephrotic syndrome. Thromb Res 23:473–479.PubMedGoogle Scholar
  199. Wardle EN (1974) Fibrin in renal disease: functional considerations. Clin Nephrol 2:85–92.PubMedGoogle Scholar
  200. Warrell RP, Hultin MB, Cover BS (1979) Increased FVIII/von Willebrand factor antigen and von Wille-brand factor activity in renal failure. Am J Med 66:226–228.PubMedGoogle Scholar
  201. Wass V, Camerson JS (1981) Cardiovascular disease and the nephrotic syndrome: the other side of the coin. Nephron 27:58–61.PubMedGoogle Scholar
  202. Wegmuller E, Grunninger V, Furlan M, Beck EA, Hodler J, Renbi F (1981) FVIII activity in chronic renal disease. Nephron 28:157–162.PubMedGoogle Scholar
  203. Weinstein MJ, Chute LE, Schmitt GW, Hamburger RH, Bauer KA, Troll JH, Janson P, Deykin D (1985) Abnormal factor VIII coagulant antigen in patients with renal dysfunction and in those with disseminated intravascular coagulation. J Clin Invest 76:1406–1411.PubMedGoogle Scholar
  204. Whitaker AN (1975) Acute renal failure in disseminated intravascular coagulation. Prog Biochem Pharmacol 9:45–64.Google Scholar
  205. Wickens D, Wilkins MH, Lunec J, Ball G, Dormandy TL (1981) Free radical oxidation (peroxidation) products in plasma in normal and abnormal pregnancy. Ann Clin Biochem 18:158–162.PubMedGoogle Scholar
  206. Willems C, Stel HV, Van Aken WG, Van Mourik JA (1983) Binding and inactivation of prostacyclin (PGI2) by human erythrocytes. Br J Haematol 54:43–52.PubMedGoogle Scholar
  207. Wing AJ, Brunner FP, Brynger et al. (1977) Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transplant Assoc 15:42.Google Scholar
  208. Winter M, Frampton G, Bennett A, Machin SJ, Cameron JS (1983a) Synthesis of thromboxane B2 in uraemia and the effects of dialysis. Thromb Res 30:265–272.PubMedGoogle Scholar
  209. Winter M, Seghatchian MJ, Cameron JS (1983b) An abnormal factor VIII molecule in uraemia? Lancet I:1112.Google Scholar
  210. Winter M, Needham J, Mackie I, Cameron JS (1984) Impaired vessel wall response to venous occlusion in patients with chronic renal failure on maintenance haemodialysis. Clin Nephrol 22:307–313.PubMedGoogle Scholar
  211. Woo KT, Whitworth JA, Kincaid-Smith P (1980) Effect of anti-platelet agents on circulating platelet aggregates in patients with glomerulonephritis. Thromb Res 20:663–668.PubMedGoogle Scholar
  212. Woods HF, Ash G, Weston MJ, Bunting S, Moncade S, Vane JR (1978) Prostacyclin can replace heparin in haemodialysis in dogs. Lancet II: 1075–1077.Google Scholar
  213. Woods HF, Ash G, Parsons V, Weston MJ (1979) Reduction of dialyser film deposition with sulphur-pyraxone. Clin Nephrol 12:122–126.PubMedGoogle Scholar
  214. Yoshida N, Aoki N (1978) Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome. Blood 52:969–977.PubMedGoogle Scholar
  215. Zimmerman SW, Moorthy AV, Dreher WH, Friedman A, Varanasi U (1983) Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis. Am J Med 75:920–927.PubMedGoogle Scholar
  216. Zuzman RM, Reuben RH, Cato AE, Cocchetto DM, Crow JW, Tolkott, Rubin M (1981) Haemodialysis using prostacyclin instead of heparin as a sole antithrombotic agent. N Engl J Med 304:934–939.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • Guy H. Neild
  • Michael P. Gordge

There are no affiliations available

Personalised recommendations